Ocugen taps Rita Johnson-Greene as CFO
Source: SeekingAlpha
2026-02-09 07:07:53 ET
More on Ocugen
- Ocugen: Why I Don't Read Too Much Into The Selloff On Phase 2 GA Data
- Ocugen, Inc. (OCGN) Discusses OCU410 Phase 2 ArMaDa Trial Data and Clinical Update for Geographic Atrophy Transcript
- Ocugen: Maintaining 'Buy' Rating On Positive OCU410ST Regulatory Developments
- Ocugen prices $22.5M common stock offering at $1.50 per share
- Ocugen posts mid-stage trial data for GA therapy
Read the full article on Seeking Alpha
For further details see:
Ocugen taps Rita Johnson-Greene as CFO
Ocugen, Inc.
NASDAQ: OCGN
OCGN Trading
5.51% G/L:
$2.4268 Last:
11,494,452 Volume:
$2.46 Open:
OCGN Latest News
March 04, 2026 08:15:00 am
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
OCGN Stock Data
$478,717,026
313,395,708
0.26%
38
N/A
Biotechnology & Life Sciences
Healthcare
US
Malvern
